Use of Recombinant Activated Factor VII in Patients Without Hemophilia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Surgery
Reference46 articles.
1. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.;Hedner;J Clin Invest,1983
2. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.;O'Connell;JAMA,2006
3. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.;Hedner;Thromb Haemost,1999
4. The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicentre study.;Hay;J Thromb Haemost,1997
5. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.;Mariani;Vox Sang,1999
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest;Therapeutics and Clinical Risk Management;2022-04
2. Use of recombinant activated factor VII for the treatment of perioperative bleeding in noncardiac surgery patients without hemophilia: A systematic review and meta-analysis of randomized controlled trials;Journal of Critical Care;2021-04
3. Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding;Dose-Response;2020-10-01
4. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?;Leukemia Research;2020-07
5. Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals;Cureus;2019-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3